Anticipatory AI Intelligence for Pharma
See the assets, risks, and opportunities before the market moves.
The Deal Environment Has Outgrown Your Tools.
Deal volume is up 76% year over year. Headcount isn’t.
85% of patent filings now originate outside the US - most from China - where Western intelligence platforms run 3–6 months behind real disclosures.
By the time a signal surfaces in your current stack, someone else has already moved
BIOPTIC monitors 50+ sources including Chinese patent databases and NMPA filings surfacing deals weeks.
BIOPTIC digests global filings, trials, and patents in hours, not months before current tools index them.
The Window Is Closing.
FDA-EMA joint AI principles took effect January 14, 2026. EU AI Act enforcement begins August 2, 2026. Non-compliant AI carries fines up to €30M. With $170B–$236B in pharma revenue at risk from patent cliffs by 2030, waiting is no longer a strategy.
BIOPTIC is built for now.
Built for the Teams That Feel This Most.
BD&L Analysts:
More deals, same team, faster decisions expected. BIOPTIC surfaces ranked, sourced intelligence before the window closes, without adding headcount.
Corporate Venture Arms:
Competitors are closing China deals you never saw coming. BIOPTIC eliminates the coverage lag that turns blind spots into career-defining misses.
CIOs and IT Leaders:
Internal AI builds cost $2M-10M and fail 80% of the time. BIOPTIC deploys in GxP-compliant environments at a fraction of the cost, without the multi-year risk.
Regulatory Affairs and Legal Teams:
Current tools weren’t built for ALCOA+ compliance or AI audit trails. BIOPTIC was.
Biotech Consultancies:
BCG and Deloitte are already offering AI-powered diligence. BIOPTIC’s white-label model lets you compete under your brand, in weeks.
CSOs and R&D Heads:
The board is asking about your AI strategy. Pfizer, Lilly, and GSK are answering. BIOPTIC gives you the infrastructure to do the same.
Get in touch
Whether you’re a researcher, potential partner, or just curious about what we’re building, drop us a message. Explore how we can push the boundaries of science and discovery.